ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269721; 2) Community: the network communities that were significantly associated with the response to NSC 269721; 3) Molecule: the relationships between components within communities and NSC 269721; 4) MDR: the compounds that were significantly associated with the NSC 269721.

NSC Compound Enrichment Correlation
NSC 716040 Null 0.00415749398947839 0.4659337
NSC 755267 Null 0.00415749398947839 0.37908025
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.00423163567577548 0.38641068
NSC 673188 - 0.00423163567577548 0.15652882
NSC 697194 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.00423163567577548 0.3749038
NSC 712742 Null 0.00423163567577548 0.2271461
NSC 107124 Camptothecin Derivative 0.00423163567577551 0.53801401
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.00423163567577551 0.35249082
NSC 251190 [1-(2-PYRIDINYL)ETHYLIDENE]HYDRAZINECARBODITHIOIC ACID, METHYL ESTER 0.00457614317494017 -0.14072142
NSC 355063 Granatomycin A 0.00457614317494024 -0.18578781
Total:61  Current:7    [First] [Prev] [Next] [Last]